Rogier T.
- Country
- The Netherlands
- Department
- Rheumatology
Research Overview
- Evaluation of Obinutuzumab-Induced Depletion of Autoreactive B Cells in Affected Tissues of Patients with Sjögren's Syndrome
- Evaluation of Filgotinib on Quality of Life, Disease Activity, and Safety in Refractory Behcet's Disease, Idiopathic Inflammatory Myopathies, and IgG4-Related Disease
- Phase IIa Double-Blind, Randomized, Placebo-Controlled Study of CIT-013 on Disease Activity in Moderately Active Rheumatoid Arthritis Patients
Data & Insights
Has run more than one trial at 2 of 29 partner sites.
Specializations
Inflammatory Disorders
The investigator specializes in treating complex immune-mediated inflammatory diseases, with particular focus on rare and challenging conditions affecting multiple body systems.
- Behcet's disease
- IgG4-related disease
- Idiopathic Inflammatory Myopathies
Their research explores innovative therapeutic approaches for managing these chronic inflammatory conditions.
Autoimmune Conditions
The investigator has developed expertise in treating dermatomyositis, an autoimmune condition characterized by muscle weakness and distinctive skin manifestations.
- Muscle inflammation management
- Autoimmune skin disorders
- Systemic therapy approaches
Their work focuses on evaluating novel therapeutic agents for improving patient outcomes in autoimmune disorders.
Treatment Innovation
The investigator evaluates advanced therapeutic options including JAK-inhibitors and other innovative compounds for treating refractory inflammatory conditions.
- Quality of life improvements
- Disease activity monitoring
- Treatment safety profiles
Their research aims to expand treatment options for patients with resistant forms of inflammatory diseases.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.